Cargando…
Overcoming scientific and structural bottlenecks in antibacterial discovery and development
Antibiotic resistance is becoming an increasing threat, with too few novel antibiotics coming to market to replace those lost due to resistance development. Efforts by the pharmaceutical industry to screen for and design novel antibacterials have not been successful, with several companies minimizin...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Informa Healthcare
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034555/ https://www.ncbi.nlm.nih.gov/pubmed/24646118 http://dx.doi.org/10.3109/03009734.2014.897277 |